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Introduction {#sec1}
============

Nuclear homeostasis has recently been the focus of attention in aggregation-prone neurodegenerative disorders. In particular, defects in nucleo-cytoplasmic transport and deregulation of nuclear matrix have been identified as potential pathomechanisms in several conditions \[[@bib1], [@bib2], [@bib3], [@bib4]\]. Mutation in genes encoding nuclear lamina constituents have been associated with degradation of nuclear components by autophagy \[[@bib5]\], in a process further defined as nucleophagy.

Autophagy affects onset and progression of several human neurodegenerative diseases, reflecting its key role as a regulator of neuronal proteostasis and organelle quality control \[[@bib6]\]. Bulk or selected cargos are recruited by autophagy receptors, like p62, to forming double-membrane vesicles, the autophagosomes, marked by the lipid-conjugated form of LC3, LC3-II. Mature autophagosomes fuse with lysosomes to form autolysosomes where the cargo is digested by lysosomal enzymes and basic molecules are recycled back to the cytoplasm \[[@bib7]\]. Nucleophagy, a selective autophagy mechanism, has been linked to LaminB1 degradation through direct interaction with LC3 as a mechanism of protection from oncogenesis and of reinforcement toward cellular senescence \[[@bib8]\]. However, the importance of nucleophagy and its relationship with neuronal degeneration has not been established.

Polyglutamine (polyQ) diseases are neurological conditions due to an expanded CAG repeat resulting in polyQ stretches in the encoded protein. This family of disorders includes Huntington's disease, dentatorubral-pallidoluysian atrophy (DRPLA), and several spinocerebellar ataxias. DRPLA is caused by the expansion of a CAG stretch in the *ATROPHIN-1* (*ATN1*) gene \[[@bib9]\]. Patients display ataxic and choreoathetoid symptoms as well as myoclonus, generalized epilepsy, and dementia with extensive cellular degeneration found in the basal ganglia (e.g., the globus pallidus, GP), brainstem (e.g., the red nucleus, RN), and cerebellum (primarily in the dentate nucleus, DN) \[[@bib10]\].

Several DRPLA mouse models have been previously generated, all recapitulating important aspects of the disease \[[@bib11], [@bib12], [@bib13]\]. We have predicted dysfunctional autophagy from previous *Drosophila* studies on DRPLA \[[@bib14], [@bib15]\]. Here, we show that progressive development of an ataxic phenotype in DRPLA mice is linked to severe cellular pathology in relevant neuroanatomical regions. We reveal that neurodegeneration is associated with a stall in canonical autophagy and the activation of alternative pathways of Golgi-dependent and nucleophagy-based degradation and excretion of LaminB1, leading to disruption of nuclear integrity and to cell atrophy.

Results {#sec2}
=======

Progression of Motor Behavior Defects in DRPLA Mice {#sec2.1}
---------------------------------------------------

The behavioral phenotypes of ATN1-FL-26Q-84 (ATN1-FL-26Q) and ATN1-FL-65Q-105 (ATN1-FL-65Q) mouse lines were evaluated in greater detail than previously reported. Compared to both wild-type (WT) mice and the ATN1-FL-26Q-84 (ATN1-FL-26Q) line, the ATN1-FL-65Q-105 (ATN1-FL-65Q) line showed clear decline in the rotarod ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B) and grip strength tests ([Figures 1](#fig1){ref-type="fig"}A--1D). This was also reflected in the earlier onset of jerky movements, tremors, hind limb clasping, seizures, and a stronger progressive lack of weight gain ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D; [Movie S1](#mmc3){ref-type="supplementary-material"}).Figure 1Behavioral Assessment of DRPLA Mice(A--D) Grip strength analysis revealed the progression of degenerative decline in ATN1-FL-65Q mice (red) compared to wild-type mice (WT, black) and ATN1-FL-26Q (blue) over time as measured by repeated-measures two-way ANOVA. This was evidenced by significant interaction between age (v1) and genotype (v2) (^X^p \< 0.05,^XX^p \< 0.01, ^XXX^p \< 0.001) when measuring both limbs (A and B). Hereby the progression was stronger in males signified by stronger interaction in both limbs (B) compared to females (A). In addition, males showed progression when only forelimb grip strength was measured (D). In contrast, females showed overall decreased non-progressive grip strength levels for fore limbs (C). Individual values are given as mean ± SEM and significance levels for individual time points are assigned above with ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001.(E) Thigmotaxis as a measure of anxiety was evaluated for the first 5 min after introduction to the open field by assessing the time 10-week-old males and females spent in the outer zone. The ATN1-FL-65Q (65Q, red) line showed a significantly higher tendency to remain close to the walls of the arena as compared to the wild-type (wt; black) and ATN1-FL-26Q (26Q; blue) mice. Automatic quantification using EthoVision 7XT software. One-way ANOVA, ^∗∗^p \< 0.01.(F) General activity was assessed in females at 10 and 14 weeks evaluating the distance traveled from 5 to 25 min after introduction to the open field. ATN1-FL-26Q (blue) mice were significantly more active compared to the wild-type (WT; black) at 10 weeks. This difference was more pronounced at 14 weeks of age with both the ATN1-FL-26Q and ATN1-FL-65Q (red) lines being more active than the wild-type, while ATN1-FL-65Q mice were less active than ATN1-FL-26Q. An interaction with age was not observed (repeated-measures two-way ANOVA, v1, genotype; v2, age). Automatic quantification using EthoVision 7XT software. One-way ANOVA ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001.(G) In gait analysis at 18 weeks of age, ATN1-FL-26Q shows a typical coordinated and regular footprint placing the hind paws (red) close to front paws (blue). In contrast, ATN1-FL-65Q shows an uncoordinated pattern typical for ataxia.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Furthermore, the ATN1-FL-26Q and ATN1-FL-65Q lines seemed to be hyperactive compared to WT. ATN1-FL-26Q mice showed increased explorative behavior ([Figure S1](#mmc1){ref-type="supplementary-material"}E; [Movie S2](#mmc4){ref-type="supplementary-material"}), while the ATN1-FL-65Q mice appeared rather aggressive and anxious, as reflected in increased thigmotaxis ([Figure 1](#fig1){ref-type="fig"}E) \[[@bib16]\]. The ATN1-FL-26Q line also showed a significant increase in general activity as compared to WT mice ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}F). ATN1-FL-65Q, but not ATN1-FL-26Q, displayed a severely altered, distinctively ataxic gait ([Figure 1](#fig1){ref-type="fig"}G).

Stall in Autophagy in DRPLA {#sec2.2}
---------------------------

Previous *Drosophila* studies indicated a blockage of autophagic clearance in DRPLA \[[@bib14]\].

Lipofuscin accumulates during aging and also in lysosomal storage disorders with dysfunctional autophagy \[[@bib17]\]. We found a significant accumulation of lipofuscin in DRPLA mouse models in several brain regions ([Figures 2](#fig2){ref-type="fig"}A--2C, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B).Figure 2Accumulation of Undigested Autophagic Structures in Cells of the Dentate Nucleus at End-Stage in DRPLA Mice(A--C) Increased accumulation of lipofuscin-like autofluorescence in the dentate nucleus of ATN1-FL-65Q (C) and a lower level of increase in ATN1-FL-26Q (B) mice compared to wild-type (A). Confocal laser scanning microscope image λex = 514 and 633. Scale bar, 10 μm. For quantification, see [Figure S1](#mmc1){ref-type="supplementary-material"}G; for examples of autofluorescence bleaching, see [Figure S2](#mmc1){ref-type="supplementary-material"}A.(D--F) Low-magnification TEM images of DN cells show an accumulation of tertiary lysosomes as electron dense vesicular structures with transparent lipid inclusions, known as lipofuscin (red arrowheads) in ATN1-FL-65Q mice (F) compared to wild-type (WT, D) and ATN1-FL-26Q (E). nuc, nucleus; mt, mitochondria; ER, endoplasmatic reticulum; mb, plasma membrane. Scale bar, 1 μm. Higher-magnification image of (F) is shown in [Figure 5](#fig5){ref-type="fig"}B.(G and H) High-magnification TEM images of tertiary (late) lysosomes resemble the typical structure of lipofuscin-packed electron dense lamellar matrix containing intravesicular lipid inclusion as an electron transparent circular structure. (G) ATN1-FL-65Q and (H) wild-type (WT). mt, mitochondria. Scale bar, 500 nm.(I) High-magnification TEM image shows dense accumulation surrounded by multiple membranes (black arrowhead) as observed in ATN1-FL-65Q dentate nucleus cells, often referred to as a multilamellar body. Scale bar, 500 nm(J) Example of a cell showing multiple accumulations of tertiary lysosomes (red arrowheads) and double-membrane autophagic vesicles (black arrowheads) containing undigested debris frequently observed in ATN1-FL-65Q dentate nucleus cells. Scale bar, 1 μm. Lower-magnification representation of the nucleus is shown in [Figure 5](#fig5){ref-type="fig"}A.(K) Magnification of the inset in (J) showing two double-membrane vesicular structures (black arrowheads), containing undigested material. Scale bar, 500 nm.(L) High-magnification image of an autophagosome (arrow), as a double-membrane vesicular structure containing several endosomes (full arrowhead), and an undigested former mitochondrion (framed arrowhead). Scale bar, 500 nm.(M) Representative images of dentate nucleus cells from WT;GFP-LC3, ATN1-FL-26Q;GFP-LC3, and ATN1-FL-65Q;GFP-LC3 end-stage mice evaluated for GFP (green) and LAMP2a (red) positive as well as colocalized (yellow) puncta. Puncta were counted within the soma of cells, showing typical morphology for DN neurons with large low-intensity nuclei (blue) surrounded by a relatively large cytoplasm and a high LAMP2a positive background. Images were taken at the nuclear level of the cell with Axiovert epifluorescence microscope using Apotome optical sectioning with high grid at 100× objective magnification. Scale bar, 10 μm.(N) Quantification of GFP-positive puncta in dentate nucleus cells of WT;GFP-LC3 (wt), ATN1-FL-26Q;GFP-LC3 (26Q), and ATN1-FL-65Q;GFP-LC3 (65Q) mice at the presymptomatic stage of 3 weeks (wt, n = 83 cells, 3 animals; 26Q, n = 77 cells, 3 animals; 65Q, n = 96 cells, 4 animals) and end-stage (wt, n = 53 cells, 3 animals; 26Q, n = 49 cells, 3 animals; 65Q, n = 52 cells, 3 animals). One-way ANOVA, mean ± SEM, ^∗∗∗^p \< 0.001, ^∗∗^p \< 0.01.(O) Relative co-localization ratio of puncta positive for both GFP-LC3 and LAMP2a to puncta positive for only GFP-LC3 in dentate nucleus cells of 3 week and end-stage WT;GFP-LC3 (wt), ATN1-FL-26Q;GFP-LC3 (26Q) and ATN1-FL-65Q;GFP-LC3 (65Q) mice. One-way ANOVA, mean ± SEM, ^∗∗^p \< 0.01, ^∗^p \< 0.05.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

This was confirmed in transmission electron microscopy (TEM) micrographs from DN cells ([Figures 2](#fig2){ref-type="fig"}D--2F) showing electron-dense tertiary lysosomes, characterized as lipofuscin, especially in the ATN1-FL-65Q mice ([Figures 2](#fig2){ref-type="fig"}F and 2G). Furthermore, in ATN1-FL-65Q we observed accumulations of multilamellar bodies ([Figure 2](#fig2){ref-type="fig"}I), and of double-membrane autophagic vesicles, often containing partially preserved debris ([Figures 2](#fig2){ref-type="fig"}J--2L), suggesting incomplete digestion.

The autophagy flux was evaluated *in vivo* using GFP-LC3 transgenic mice \[[@bib18]\]. DN cells in ATN1-FL-65Q mice showed a significant increase in GFP-LC3 puncta, as early as 3 weeks of age, with further increase observed in end-stage animals ([Figures 2](#fig2){ref-type="fig"}M and 2N). Similar effects were observed in the RN in the brainstem ([Figure S2](#mmc1){ref-type="supplementary-material"}E), but not in the GP ([Figure S2](#mmc1){ref-type="supplementary-material"}F) and in any other forebrain region ([Figure S2](#mmc1){ref-type="supplementary-material"}E). The ATN1-FL-26Q line showed an initial increase of GFP-LC3 puncta in the DN at 3 weeks but not at end-stage ([Figures 2](#fig2){ref-type="fig"}M and 2N) in any of the brain areas analyzed ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F).

The number of LAMP2A positive lysosomes did not differ across genotypes ([Figure S2](#mmc1){ref-type="supplementary-material"}C); however, the number of GFP-LC3/LAMP2A double-positive autolysosomes was increased in ATN1-FL-65Q (and partially in ATN1-FL-26Q) DN cells at 3 weeks ([Figure S2](#mmc1){ref-type="supplementary-material"}D). At end-stage, normalizing the GFP-LC3/LAMP2A double-positive puncta, over the total of GFP-LC3 puncta (reflecting the ratio of autolysosomes over the total of autophagic vesicles) the number of autolysosomes had actually decreased in the ATN1-FL-65Q and ATN1-FL-26Q lines ([Figure 2](#fig2){ref-type="fig"}O). This contrasts with the initial increase at 3 weeks of age in the ATN1-FL-65Q, suggesting a change in the status of autophagy with pathology progression.

We also biochemically analyzed autophagy on a global scale. The extraction process separated a liquid supernatant from a pellet fraction. No changes were detected at 3 weeks of age for GFP-LC3 and p62 in any brain area ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Thus, the mild autophagic flux alterations observed at this stage are limited to the DN of DRPLA mice. However, pronounced global defects become apparent at the symptomatic stage. In the 14 weeks cerebellum, there was a significant downregulation of the Atg5-12 conjugate formation and of the GFP-LC3-II/-I ratio ([Figures 3](#fig3){ref-type="fig"}A--3C), as well as of GFP-LC3-II ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D) in ATN1-FL-65Q in the supernatant fraction, which was accompanied by a significant increase in the cleaved GFP/GFP-LC3 ratio and of the levels of p62 in the pellet ([Figures 3](#fig3){ref-type="fig"}D--3F). These changes were also maintained at end-stage ([Figure 3](#fig3){ref-type="fig"}G).Figure 3Inhibition of Autophagy Flux at Lysosomal Level and Decrease in Autophagy Initiation Signaling in DRPLA(A--C) The ratio of LC3II to LC3I was used to quantify autophagic flux in western blot analysis of full-length GFP-LC3 in the supernatant fraction of cerebellar lysates at 14 weeks of age (A). The anti-LC3 antibody recognizes a doublet between 35 and 55 kDa ([Figure S4](#mmc1){ref-type="supplementary-material"}B), consistent with GFP-LC3-I (upper) and cleaved GFP-LC3-II (lower). The level of Atg5-12 conjugate was used to quantify the events of autophagy initiation. Densitometric analysis shows a decreased relative abundance of cleaved GFP-LC3-II to full-length GFP-LC3-I (B) in ATN1-FL-65Q;GFP-LC3 (65Q) mice compared to ATN1-FL-26Q;GFP-LC3 (26Q) and WT;GFP-LC3 (wt) mice. Atg5-12 conjugate (C) is also decreased in ATN1-FL-65Q;GFP-LC3 (65Q) compared to WT;GFP-LC3 (wt). Student's t test, mean ± SEM, ^∗∗^p \< 0.01, ^∗^p \< 0.05.(D--F) The accumulation of GFP cleavage product and autophagy receptor p62 was analyzed as a measure of autophagy flux blockage in western blot assay of the cerebellar lysates at 14 weeks of age (D). Mouse anti-GFP antibody recognizes only GFP-LC3-II ([Figure S4](#mmc1){ref-type="supplementary-material"}B) and cleaved GFP after longer exposure. ^∗^Shorter exposure of anti-GFP signal. Densitometric analysis of the relative abundance of cleaved GFP to GFP-LC3-II (E) as well as the abundance of p62 relative to α-tubulin (F) in WT;GFP-LC3 mice (wt), ATN1-FL-26Q;GFP-LC3 (26Q) and ATN1-FL-65Q;GFP-LC3 (65Q) mice. Student's t test, mean ± SEM, ^∗^p \< 0.05.(G) Accordingly, western blot analysis of autophagy shows a stall in autophagy flux in end-stage ATN1-FL-65Q mice compared to wild-type (WT) as evidenced by relative decrease of GFP-LC3-II as well as increase of p62 in the pellet fraction. ^∗^Anti-p62 antibody revealed an additional band 20 kDa above the expected band at around ∼60 kDa in the supernatant fractions of the cerebellum in end-stage mice.(H) qPCR analysis of *Tfeb* mRNA levels in the cerebellum of wild-type (wt, white), ATN1-FL-26Q (26Q, blue) and ATN1-FL-65Q mice (65Q, red) at presymptomatic (3 weeks) and early symptomatic (10 weeks) time points. Relative levels normalized to *β-actin* and *Hprt1* are given as a fold change of wild-type. Two-way ANOVA, v1, genotype; v2, age, mean ± SEM (n = 6), ^∗∗∗^p \< 0.001.(I and J) Levels of Tfeb protein in the supernatant fraction of cerebellar lysates at 14 weeks of age (I). Densitometric analysis (J) reveals a significant decrease in ATN1-FL-65Q;GFP-LC3 (65Q) compared to WT;GFP-LC3 (wt). One-way ANOVA, mean ± SEM, ^∗∗^p \< 0.05.(K) qPCR analysis of *Ctsb and Prkag* mRNA levels in the cerebellum of wild-type (wt, white), ATN1-FL-26Q (26Q, blue) and ATN1-FL-65Q mice (65Q, red) at an early symptomatic (10 weeks) time point. Relative levels normalized to *Hprt1* are given as a fold change of wild-type. One-way ANOVA, mean ± SEM (n = 6), ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.(L) Whole-cell lysates of human fibroblasts from healthy control and DRPLA patients were subjected to western blot analysis for endogenous LC3-I and LC3-II as well as p62. Induction of autophagy with Rap and block with BafA1 for 6 hr resulted in increase of LC3II compared to DMSO in control fibroblasts, while there was no acute response observed in DRPLA patient samples. No changes in p62 levels were evident after 6 hr acute treatment.(M and N) Analysis of the autophagy flux in control and DRPLA fibroblasts (DRPLA 17) transfected with the tandem RFP-GFP-LC3B reporter. Starvation in Hank's balanced salt solution (HBSS) medium was used to induce autophagy, BafA1 treatment to inhibit lysosomal degradation. Autophagosomes are marked by yellow signal as a result of combined RFP and GFP double fluorescence. Due to quenching of the GFP signal in acidic environment autolysosomes show RFP fluorescence only. Representative images acquired with Nikon spinning disc confocal microscope display a greater amount of autophagosomes and autolysosomes in control fibroblasts compared to DRPLA after starvation in HBSS for 3 hr (M). Quantification in (N) demonstrates a significant increase in both autophagosomes and autolysosomes in control but not in DRPLA cells after starvation. Addition of BafA1 to starvation medium resulted in a greater number of GFP^+^RFP^+^ puncta as compared to starvation only in control cells. No changes were significant in DRPLA patient fibroblasts (see also [Figure S6](#mmc1){ref-type="supplementary-material"}H). Significance values in the columns show differences for fed versus starved condition and starved versus +BafA1 condition for RFP^+^ or GFP^+^RFP^+^ puncta. One-way ANOVA, mean ± SEM, ^∗^p \< 0.05, ^∗∗∗^p \< 0.001. Significance values between control and DRPLA cells for overall puncta are shown above the horizontal bars, two-way ANOVA ^∗∗∗^p \< 0.001; v1, genotype; v2,- total GFP^+^ and GFP^+^RFP^+^ puncta. Scale bar, 20 μm.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

A similar, albeit somewhat delayed, effect to that in the cerebellum was visible in the brainstem lysates of the ATN1-FL-65Q line ([Figures S3](#mmc1){ref-type="supplementary-material"}E--S3K). The ATN1-FL-26Q line appeared comparable to WT, except for a decrease in the cleaved GFP/GFP-LC3 ratio at 14 weeks of age ([Figures S3](#mmc1){ref-type="supplementary-material"}I and S3J). Finally, no autophagy alteration was detected in the forebrain at any time point ([Figure S3](#mmc1){ref-type="supplementary-material"}L).

Despite robust similarities indicating block at lysosomal level as observed in *Drosophila* DRPLA models, in DRPLA mice we detected additional events that indicate the presence of feedback inhibition on autophagy signaling.

The alterations in the cerebellum at the symptomatic stage of 14 weeks are consistent with a block in autophagic clearance, combined with a reduction in signaling required for the formation of new autophagosomes, perhaps result of a feedback loop. In agreement with this, we detected a reduction in phosphorylation of Atg13 on S318 ([Figure S4](#mmc1){ref-type="supplementary-material"}A) and a significant decrease in mRNA and protein levels of Tfeb ([Figures 3](#fig3){ref-type="fig"}H--3J), the master regulator of the autophagosome-lysosome system \[[@bib19]\]. The feedback loop did not appear to be mediated by activation of mTOR, which displayed rather a trend toward inactivation, as shown by phosphorylation of p70S6 kinase ([Figure S4](#mmc1){ref-type="supplementary-material"}A). The repression of Tfeb in ATN1-FL-65Q mice is also indicated by absence from the nucleus of DN neurons ([Figure S4](#mmc1){ref-type="supplementary-material"}B), and decreased transcription of at least two of its target genes ([Figure 3](#fig3){ref-type="fig"}K). The ATN1-FL-26Q line showed almost no difference from WT with the exception of a mild reduction in the GFP-LC3-II/-I ratio ([Figures 3](#fig3){ref-type="fig"}A and 3B) and GFP-LC3-II ([Figures S3](#mmc1){ref-type="supplementary-material"}I and S3J) at 14 weeks in the cerebellum, as well as a tendency to reduction in mTOR signaling ([Figure S4](#mmc1){ref-type="supplementary-material"}A).

To validate whether the stall in autophagy signaling in DRPLA is present also in human cells, we used fibroblast lines from two DRPLA patients. The human fibroblasts failed to respond to acute 6-hr treatment with the autophagy inducer Rapamycin (Rap) or with the autophagy clearance blocker Bafilomycin A1 (BafA1), whereas a control fibroblast line displayed the typical increase in LC3I to LC3II conversion, upon Rap treatment, as well as increased accumulation of LC3II, upon treatment with BafA1 ([Figure 3](#fig3){ref-type="fig"}L). Chronic 24-hr treatment with BafA1 elicited a modest but reproducible response from the DRPLA human fibroblasts, including significant reduction in LC3I/II conversion and accumulation of p62 ([Figures S4](#mmc1){ref-type="supplementary-material"}C--S4G), suggesting a block in autophagosomal biogenesis. We further confirmed the block in autophagosome formation in DRPLA cells with the tandem reporter RFP-GFP-LC3B ([Figures 3](#fig3){ref-type="fig"}M and 3N). The ratio between RFP^+^ and RFP^+^/GFP^+^ positive puncta in DRPLA cells did not increase with starvation and was also not affected by additional treatment with BafA1, suggesting also impaired progression and clearance of the few autophagosomes present ([Figure S4](#mmc1){ref-type="supplementary-material"}H). Thus, patients' cells display the same phenotype detected at late stages in the progression of cellular pathology in DRPLA mice, i.e., canonical autophagy signaling, the formation of new autophagosomes, and their clearance are stalled.

Nuclear Degeneration through Nucleophagy-Based Cytoplasmic Displacement of LaminB1 following Block in Canonical Autophagy {#sec2.3}
-------------------------------------------------------------------------------------------------------------------------

In parallel with autophagy stalling, we detected prominent nuclear pathology in DRPLA mice. In DN neurons, there was a striking accumulation of p62 inside the nucleus of the ATN1-FL-65Q mice with the formation of a large inclusion ([Figure 6](#fig6){ref-type="fig"}Aiii), which appeared to be composed of smaller aggregates at end-stage ([Figure S5](#mmc1){ref-type="supplementary-material"}A). The abnormal nuclear accumulation of p62 suggests a specific pathological defect in the nucleus. TEM analysis of DN neurons revealed that at end-stage these cells have a strikingly deformed nucleus ([Figure 4](#fig4){ref-type="fig"}A; see also [Figure 6](#fig6){ref-type="fig"}Ai), with parts bulging out, especially those rich in heterochromatin, and with the appearance of vacuolar-like structures at the periphery. Reviewing previous TEM data, we noticed that nuclear deformation was also present in *Drosophila* DRPLA models and *fat* mutants \[[@bib14], [@bib15]\]. Indeed, also in the *Drosophila* central brain, the normal circular organization of LaminB in the cortex of neuronal nuclei is significantly altered and irregular in aged DRPLA flies, with some cells showing ruffles and gaps ([Figures 4](#fig4){ref-type="fig"}B and 4C). Most interestingly, human control fibroblasts lose the normal LaminB1 organization and display inward ruffles of the lamin layer when treated with BafA1 for 48 hr ([Figure 4](#fig4){ref-type="fig"}D). DRPLA fibroblasts also display LaminB1 inward ruffles when treated with BafA1 and, remarkably, also when treated with Rap for 48 hr ([Figure 4](#fig4){ref-type="fig"}D). In addition, whereas both control and DRPLA cells reduce their nuclear size when treated with Rap and BafA1 ([Figure 4](#fig4){ref-type="fig"}E), only control fibroblasts increase the roundness of their nucleus, opposite to DRPLA fibroblasts ([Figure 4](#fig4){ref-type="fig"}F). This indicates that human DRPLA cells respond differently than control cells to Rap and BafA1 and that chronic blockage of the autophagy-lysosome clearance by BafA1 makes control and patient cells converge toward parameters characteristic of DRPLA nuclei ([Figure 4](#fig4){ref-type="fig"}G).Figure 4Loss of Nuclear Integrity in Mouse and *Drosophila* Models for DRPLA and in DRPLA Patients' Fibroblast(A) TEM images of dentate nucleus cells in wild-type (WT, top) and ATN1-FL-65Q (bottom) mice. The latter is displaying irregular shaped nuclei, where the electron dense structures (heterochromatin) are bulging out at the periphery (arrow) with electron-lucent vacuolar-like structures (arrowheads). nuc, nucleus. Scale bar, 5 μm.(B and C) Overexpression of *Drosophila* polyQ Atrophin and *LacZ* as a control using the UAS-Gal4 system specifically in adult glial and neuronal cells driven by *repo* and *elav* promotors. The expression was induced in fully developed adult flies for 14 days by utilizing ubiquitously expressed temperature sensitive *Gal4* repressor *UbiGal80*^*TS*^ and inactivated at 29°C. The confocal images of *Drosophila* LaminB show irregular lamina (arrowheads) in *sAtro75QN* overexpressing flies compared to *LacZ* expressing flies (B), which is reflected in significant loss of circularity (ImageJ, particle analysis): mean ± SEM, n = 5, Student's t test ^∗∗∗^p \< 0.001 (C).(D--G) Analysis of nuclear shape dynamics in DRPLA (17) patient fibroblasts and age-matched control after 48-hr treatment with Rap and BafA1. Representative images show folding of nuclear envelope revealed by the aLaminB1 antibody upon treatment with BafA1 in both control and DRPLA (arrows), while Rap induced folding (arrowhead) in DRPLA fibroblasts (D). The structural changes were reflected by a decrease in nuclear size after treatment in both control and DRPLA cells (E). While the nuclear roundness decreased in DRPLA cells, it increased in controls (F). The plot of roundness versus area shows an opposite trend and convergence of controls and DRPLA nuclei upon BafA1 treatment (G). Automated quantification was performed using Opera Phenix high-content screening system and Columbus software. Mean ± SEM, n = 5, two-way-ANOVA ^∗∗∗^p \< 0.001, ^∗^p \< 0.05; v1, genotype; v2, treatment. Scale bar, 50 μm.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Next, we have tested nuclear shape dynamics in fibroblasts from Vici syndrome (VS) patients. VS is an early-onset infantile multisystem disorder with well-characterized autolysosomal blockage due to mutations in the *EPG5* gene \[[@bib20], [@bib21]\], which is required for the autophagosome-lysosome fusion \[[@bib22]\]. VS fibroblasts displayed similar nuclear shape dynamics as the DRPLA fibroblasts upon 48-hr BafA1 treatment ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). Interestingly, the age-matched (3 years old) control cells were hardly affected by this treatment, in contrast to the age-matched (51 years old) DRPLA controls, probably reflecting different resistance and plasticity, due to the age difference.

Furthermore, in human neuroblastoma cells SK-N-BE(2) transfected with mCherry-LaminB1, genetic block of autophagy by Atg6 small interfering RNA (siRNA) decreased the roundness of the nucleus ([Figures S5](#mmc1){ref-type="supplementary-material"}D and S5E). A similar trend was displayed after Atg5 knockdown.

We therefore reasoned that defects in nuclear shape dynamics may be linked to the recently reported role of autophagy in the degradation of nuclear lamina \[[@bib8]\] and have analyzed LaminB1 interaction with the autophagy machinery. In DN neurons, LaminB1 is distributed in speckles of puncta throughout the nucleus. In ATN1-FL-65Q mice, we detected a significant accumulation of larger LaminB1 dots in the cytoplasm ([Figures 5](#fig5){ref-type="fig"}A and 5B), which was one of the earliest cellular phenotypes detected at 3 weeks in these mice ([Figures S7](#mmc1){ref-type="supplementary-material"}E and S7H). At end-stage, many of the LaminB1 puncta co-localized with GFP-LC3 ([Figures 5](#fig5){ref-type="fig"}A, 5C, and [S6](#mmc1){ref-type="supplementary-material"}A) in particular in the ATN1-FL-65Q line ([Figure 5](#fig5){ref-type="fig"}C). While some of the brighter dots localize in close proximity or co-localize directly with p62, also in WT and ATN1-FL-26Q lines, the majority displayed a segregated distribution ([Figure S5](#mmc1){ref-type="supplementary-material"}A). In particular, many more puncta were detected in ATN1-FL-65Q mice, but there was no overall overlap with the intranuclear p62 inclusion ([Figure S5](#mmc1){ref-type="supplementary-material"}A). In contrast, many LaminB1 puncta co-localized with polyQ protein aggregates, mostly inside the nucleus, but also in the cytoplasm in DN neurons ([Figure 5](#fig5){ref-type="fig"}D) and Purkinje and granule cells ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Despite the reduced number of polyQ dots in WT and ATN1-FL-26Q lines, some co-localization could be observed also in these cases ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). In granule cells, ATN1-FL-65Q induced complete disorganization of nuclear LaminB1 at end-stage ([Figure S6](#mmc1){ref-type="supplementary-material"}B), whereas at 3 weeks only early signs of incomplete circular organization were detectable ([Figure S6](#mmc1){ref-type="supplementary-material"}C). Interestingly, overexpression of ATN1-FL-26Q at end-stage was sufficient to induce a disorganization of LaminB1 in some cells (e.g., granule cells, [Figure S6](#mmc1){ref-type="supplementary-material"}B), but not in others (e.g., DN neurons).Figure 5Lamin-Based Nucleophagy Associates with PolyQ Inclusions in DRPLA Mice and Is Aggravated in Human DRPLA Fibroblasts upon Lysosomal Blockage(A--C) Representative images of dentate nucleus cells from WT;GFP-LC3 (WT, left), ATN1-FL-26Q;GFP-LC3 (middle), and ATN1-FL-65Q;GFP-LC3 (right) end-stage mice show co-localization (yellow) of GFP-LC3 (green) and LaminB1 (red) in the nucleus (framed arrowheads) and, in particular, in the cytoplasm (full arrowheads) of ATN1-FL-65Q cells (A). The nucleus is visualized in blue. Single-plane images were taken with the confocal laser scanning microscope. Quantification indicates a significant increase in the amount of cytoplasmic LaminB1 (B) and of its co-localization with GFP-LC3 (C) in ATN1-FL-65Q;GFP-LC3 mice compared to WT;GFP-LC3 and ATN1-FL-26Q;GFP-LC3. One-way-ANOVA ^∗∗∗^p \< 0.001, ^∗^p \< 0.05. Scale bar, 5 μm.(D) Some nuclei in ATN1-FL-65Q;GFP-LC3 show strong degeneration reflected in LaminB1 reorganization forming bright intranuclear puncta. Intranuclear (framed arrowheads) and also cytoplasmic (full arrowheads) LaminB1 puncta colocalize with PolyQ positive puncta. Scale bar, 5 μm.(E and F) Analysis of LaminB1 redistribution into the cytoplasm in DRPLA patient fibroblasts and age-matched control after 48- and 72-hr treatment with Rap and BafA1. Representative images show cells after 72-hr treatment visualized with α-LaminB1 antibody (E). Upon treatment with BafA1 both control (white) and DRPLA (red) fibroblasts show an increase in LaminB1 positive puncta after 48 and 72 hr, while Rap increased cytoplasmic LaminB1 puncta only after 72 hr in DRPLA fibroblasts (F). In line the effect inhibitory effect of mTOR on proliferation, Rap resulted in significant decrease of relative cell number (p \< 0.001 not shown). BafA1 treatment for 48 hr resulted in decreased cell number only in DRPLA samples in contrast to controls, while after 72 hr there was a significant reduction in cell number in both control and DRPLA samples. Automated quantification was performed using Opera Phenix high-content screening system and Columbus software. Mean ± SEM, two-way-ANOVA ^∗∗∗^p \< 0.001. Scale bar, 50 μm.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Neuronal cell degeneration in the ATN1-FL-65Q mice correlates with the increased localization of LaminB1 into the cytoplasm early on. This likely relates to the disruption of the nuclear shape ([Figure 5](#fig5){ref-type="fig"}A), the severe alterations in DNA and chromatin appearance ([Figure S6](#mmc1){ref-type="supplementary-material"}E) and the increased levels of γH2AX ([Figures S6](#mmc1){ref-type="supplementary-material"}F and S6G), a marker of senescence and DNA damage \[[@bib23]\].

We used human DRPLA fibroblasts for further functional analysis. Here, we also detected a significantly higher number of cytoplasmic LaminB1 puncta after 48 hr ([Figures 5](#fig5){ref-type="fig"}E and 5F). Block of lysosomal clearance with BafA1 strikingly augmented cytoplasmic LaminB1, overpowering any difference between DRPLA and control fibroblasts. Longer culturing for 72 hr led to an overall increase in cytoplasmic LaminB1 eliminating the difference between control and DRPLA fibroblasts, potentially masked by disappearance of more severely affected DRPLA cells. However, 72-hr Rap treatment had an extraordinary effect in DRPLA fibroblasts (not seen in control cells) on the accumulation of cytoplasmic LaminB1 ([Figures 5](#fig5){ref-type="fig"}E and 5F). Interestingly, BafA1 treatment had a progressive effect on cell death with control fibroblasts displaying a significant reduction in cell number only after 72 hr ([Figure 5](#fig5){ref-type="fig"}F), whereas DRPLA fibroblasts displayed a significant decrease in cell number already at 48 hr ([Figure 5](#fig5){ref-type="fig"}F) probably due to exacerbation of an already present blockage in the autophagy-lysosome clearance.

Overall, these data in mice and human cells suggest that a stall in canonical autophagy triggers an accumulation of LaminB1 in the cytoplasm, which correlates with nuclear degeneration in DRPLA mice and cell death in human fibroblasts.

Degradation and Excretion of Cytoplasmic LaminB1 during Cell Degeneration {#sec2.4}
-------------------------------------------------------------------------

In Ras-induced cancer models, nucleophagy has been shown to result in the lysosomal degradation of LaminB1 through autophagy \[[@bib8]\]. However, given the stall in autophagy in DRPLA or following BafA1 treatment, we reasoned that alternative clearance routes may be employed for the LaminB1 accumulated in the cytoplasm.

TEM investigation of ATN1-FL-65Q DN cells also suggests that alternative routes to canonical autophagy may be active in DRPLA. Remarkable perinuclear membranous accumulation ([Figure 6](#fig6){ref-type="fig"}A), which surrounded cytoplasmic components enriched with electron dense spots ([Figure 6](#fig6){ref-type="fig"}Aii). Similar structures have been referred to as aggresomes \[[@bib24]\], which are formed close to the nucleus upon strong autophagy induction in association with p62 and LC3. Indeed, some DN cells formed a perinuclear p62- and GFP-LC3-positive structure ([Figure 6](#fig6){ref-type="fig"}Aiii). A general disorganization of intracellular membranes in the ATN1-FL-65Q cells was observed ([Figures 2](#fig2){ref-type="fig"}D--2F), also in the distal cytoplasmic regions, where long phagophore-like structures were formed ([Figure 6](#fig6){ref-type="fig"}B). Given the abnormal membrane organization, we reasoned that endoplasmatic reticulum (ER) stress could have been induced, also known to induce autophagy \[[@bib25]\]. *Bip* and *Chop* are ER-stress-responsive genes that are known to be regulated by all three pathways, *Bip* predominantly by the ATF6 pathway and *Chop* predominantly by the PERK pathway. The splicing of the mRNA encoded by the *Xbp1* gene is selectively regulated by the IRE1 pathway. We find a significant increase of Bip but not spliced Xbp1 and Chop mRNAs in the ATN1-FL-65Q mouse line at pre-symptomatic stages ([Figure S7](#mmc1){ref-type="supplementary-material"}A), but this is not sustained at early symptomatic stages, with the proapoptotic Chop being significantly downregulated ([Figure S7](#mmc1){ref-type="supplementary-material"}B).Figure 6Aggresome-like Formation and Golgi-Mediated Degradation as Signs of Alternative Autophagy Induction in the Dentate Nucleus of DRPLA Mice(A) (i) TEM image of a dentate nucleus cell in ATN1-FL-65Q mouse containing a membranous aggresome-like (Agg) accumulation in close proximity to the cell nucleus (nuc). Scale bar, 5 μm. (ii) Higher magnification of the inset in (i) containing the aggresome-like (Agg) membranous formation. Scale bar, 500 nm. ly, lysosome; mt, mitochondrion. (iii and iii') confocal fluorescence image of DN cell in ATN1-FL-65Q;GFP-LC3 mouse brain with p62 positive (red) inclusion inside the nucleus (blue) as well as outside of the nucleus (arrowhead), which also co-localizes with GFP-LC3 (green).(B) (i) TEM image of a dentate nucleus cell in ATN1-FL-65Q mice; in addition to a large perinuclear aggresome-like (Agg) structure, long membranous formations (arrowhead) with phagophore-like structure are shown at the distal side of the cell soma. Scale bar, 2 μm (note this is a higher-magnification cutout of the image in [Figure 2](#fig2){ref-type="fig"}F). (ii) High-magnification TEM image of a similar phagophore-like structure. Scale bar, 300 nm.(C) Representative TEM images of dentate nucleus cells show double-membrane vesicular structures (arrowheads) in close proximity to the Golgi apparatus (arrow) in ATN1-FL-65Q mice (right), compared to normal Golgi morphology in ATN1-FL-26Q (middle) and wild-type (WT, left) mice. Scale bar, 500 nm(D and E) Confocal fluorescence microscopy images of dentate nucleus cells showing an enlarged Golgi apparatus (GM130, red) in ATN1-FL-65Q;GFP-LC3 mouse line (left) compared to ATN1-FL-26Q;GFP-LC3 line (middle) and WT;GFP-LC3 (WT, right) (D). Inset in the bottom row shows a higher magnification of a GFP-LC3 (green) positive puncta in close proximity to GM-130 positive structures. Scale bar, 5 μm. Quantification of GM130 signal evidences an increase in the ATN1-FL-65Q;GFP-LC3 mouse line (E). Kruskal-Wallis multiple comparison analysis, mean ± SEM, ^∗∗∗^p \< 0.001(F and G) Analysis of LaminB1 redistribution into the cytoplasm in DRPLA (17) patient fibroblasts after 48-hr treatment with BafA1 and/or BrefA. BrefA was only added for the last 24 hr. BafA1 and BrefA display an increased localization of LaminB1 into the cytoplasm showing different distribution patterns: diffused after BafA1 treatment only and concentrated in large perinuclear puncta after BrefA treatment. Combined BafA1 and BrefA treatment shows synergistic effect on cytoplasmic LaminB1 localization. Scale bar, 50 μm (F). Automated quantification of area occupied by LaminB1 positive puncta in the cytoplasm was performed using Opera Phenix high-content screening system and Columbus software. Mean ± SEM, two-way ANOVA ^∗∗∗^p \< 0.001, ^∗∗^p \< 0.01, ^∗^p \< 0.05.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

We then analyzed at end-stage the other major source of intracellular membranes, the Golgi apparatus, reported to participate in autophagy \[[@bib26], [@bib27]\] also as non-canonical Golgi membrane-associated degradation (GOMED) in Atg5- and 7-deficient cells \[[@bib28], [@bib29]\]. Relatively large double-membrane vesicular structures, in some cases rather complex with vesicles apparently enclosed in each other ([Figure 6](#fig6){ref-type="fig"}C) were evident in the ATN1-FL-65Q line. In addition, the Golgi marker GM130 localized in enlarged tubular structures in the ATN1-FL-65Q DN cells at end-stage, in close proximity to GFP-LC3 puncta ([Figure 6](#fig6){ref-type="fig"}D). The whole GM130 compartment displayed an increase in size in end-stage ATN1-FL-65Q DN cells compared to ATN1-FL-26Q and a similar trend toward WT, with a significant shift in the cell distribution toward larger Golgi size ([Figures 6](#fig6){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}C). This phenotype was not seen at an earlier stage ([Figures S7](#mmc1){ref-type="supplementary-material"}E and S7F); however, the Golgi was significantly, albeit only transiently, more fragmented at 3 weeks in ATN1-FL-26Q and ATN1-FL-65Q mice ([Figures S7](#mmc1){ref-type="supplementary-material"}D, S7E, and S7G). Golgi fragmentation has been associated with induction of non-canonical autophagy \[[@bib30]\].

These data indicate an evolution of Golgi pathology from early stages in DRPLA mice. To assess the mechanistic role of the Golgi in the accumulation of cytoplasmic LaminB1, we treated human DRPLA fibroblasts with Brefeldin A (BrefA), which compromises Golgi integrity and function \[[@bib31]\]. BrefA treatment per se induced dramatic LaminB1 cytoplasmic accumulation in DRPLA fibroblasts, synergistic to the previously described BafA1 effect ([Figures 6](#fig6){ref-type="fig"}F and 6G). Morphologically, in comparison to BafA1, BrefA induced the formation of larger LaminB1 puncta in a circular perinuclear pattern ([Figure 6](#fig6){ref-type="fig"}F), suggestive of an organization around cellular organelles rather than diffused cytoplasmic spreading. As in DRPLA, EPG5-deficient VS cells displayed a significant increase in the accumulation of LaminB1 in the cytoplasm with respect to controls in control conditions, as well as under a number of treatments ([Figures S7](#mmc1){ref-type="supplementary-material"}I and S7J). Importantly, a synergic effect of BafA1 with BrefA was observed, while no synergy was displayed between BafA1and Rap.

Overall, these data indicate that the Golgi is involved in the degradation of cytoplasmic LaminB1, through a separate mechanism from that of canonical autophago-lysosomal digestion. Many of these characteristics are shared by the recently described GOMED pathway \[[@bib29]\].

However, we find that not all LaminB1 that localizes to the cytoplasm is degraded. In DRPLA fibroblasts, cells rich in cytoplasmic LaminB1 puncta excrete small bodies containing LaminB1 and p62 ([Figure 7](#fig7){ref-type="fig"}A). SK-N-BE(2) human neuroblastoma cells, co-transfected with constructs encoding cytoplasmic EGFP and an mCherry-LaminB1 chimeric protein, display similar significant increase in cytoplasmic LaminB1 upon BafA1 treatment ([Figures S7](#mmc1){ref-type="supplementary-material"}K and S7L). In these cells, we were able to visualize LaminB1 exit from the nucleus, trafficking to the cell surface and expulsion from the cytoplasm ([Figure 7](#fig7){ref-type="fig"}B; [Movie S3](#mmc5){ref-type="supplementary-material"}). In this slow excretion process, the LaminB1-containing buds appear to remain in close proximity of the cell for prolonged time after expulsion from the cytoplasm, suggesting a link may be retained ([Movie S3](#mmc5){ref-type="supplementary-material"}). Most interestingly, co-transfection of siRNA against key autophagy genes Atg5 and Atg6 increases the excretion of LaminB1 in these cells ([Figure 7](#fig7){ref-type="fig"}C). We subsequently analyzed the culture medium of DRPLA fibroblasts, using ultracentrifugation to further characterize the excretion products. LaminB1 in the medium (and in the cytoplasm) appears as a fragment ([Figure 7](#fig7){ref-type="fig"}D), possibly resulting from proteolysis of the full-length LaminB1 upon exit from the nucleus. The excreted LaminB1 fragment also specifically accumulates in the 100,000 × *g* fraction upon ultracentrifugation ([Figure S7](#mmc1){ref-type="supplementary-material"}M), which is known to be enriched in microvescicles and exosomes but not apoptotic bodies. Treatment with BafA1 and BrefA, which significantly increases the amount of LaminB1 in the cytoplasm ([Figures 7](#fig7){ref-type="fig"}D and 7E), also facilitates a dramatic increase in LaminB1 and p62 in the culture medium ([Figures 7](#fig7){ref-type="fig"}D--7G). BrefA treatment, in combination with BafA1, did not impair significantly the excretion of LaminB1 or p62 ([Figure 7](#fig7){ref-type="fig"}F).Figure 7Excretion of LaminB1-Rich Buds following Autophagy and Golgi Impairment(A) Representative image showing DRPLA (17) fibroblasts after 72 hr Rap treatment showing formation of buds at the plasma membrane containing LaminB1 and p62 puncta. High magnification of insets in the image is shown on the left. Scale bar, 25 μm.(B) Still frames (taken form [Movie S3](#mmc5){ref-type="supplementary-material"}) of confocal live imaging of a SK-N-BE(3) neuroblastoma cell expressing EGFP and mCherry-LaminB1 treated with BafA1 for 48 hr. Arrow points at a LaminB1 punctum detaching from the nucleus and getting slowly excreted over time. Note the misshapen nucleus and LaminB1 infolding. Scale bar, 5 μm.(C) Analysis of extracellular LaminB1 in SK-N-BE(2) neuroblastoma cells co-expressing EGFP and mCherry-LaminB1 as well as siRNAs against *ATG5* or *ATG6,* genes participating in autophagy and ATG-dependent secretion. Extracellular LaminB1-mCherry puncta were enriched in the surrounding region to EGFP positive cells void of EGFP signal. Automated quantification of mCherry signal intensity was performed using Opera Phenix high-content screening system and Columbus software. Mean ± SEM, one-way-ANOVA ^∗^p \< 0.05.(D--G) Analysis of excretion of cellular component in the medium of human DRPLA (17) fibroblasts treated with BafA1 and BrefA as in [Figure 6](#fig6){ref-type="fig"}F. The medium supernatant was collected and subjected to ultracentrifugation, while the cells were lysed separating nuclear and cytoplasmic fractions. BafA1 and combined BafA1/BrefA treatment increase the amount of LaminB1 in the cytoplasmic fraction (D and E). BafA1 increased significantly the amount of LaminB1 (D and F) and p62 (D and G) in the medium supernatant fraction collected after 100,000 × *g* ultracentrifugation; addition of BrefA did not significantly reduce the amount of LaminB1 or p62 found in this fraction. Note that the LaminB1 band in cytoplasmic and medium supernatant fraction runs at a lower molecular weight of ∼45 kDa as opposed to the expected ∼70 kDa in the nuclear fraction, compatible with proteolytic cleavage. Densitometry of medium supernatant fractions was standardized over cytoplasmic tubulin representing the amount of cells and cytoplasm present in the culture. One sample t test, mean ± SEM, ^∗∗^p \< 0.01, ^∗^p \< 0.05.(H) Representative image of SK-N-BE(2) neuroblastoma cells expressing EGFP, mCherry-LaminB1, and Atg6 siRNA shows the uptake of LaminB1 puncta by neighboring cells. Arrow points at mCherry-LaminB1 dots found inside non-transfected cells. Phalloidin is used to mark the cytoplasmic area of all cells. Scale bar, 10 μm.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Taken together, these data indicate that autophagy inhibition and Golgi impairment increase the amount of LaminB1 and p62 excreted in buds, which share many characteristics of microvesicles.

In neuroblastoma cells in culture, mCherry-LaminB1 puncta can be found inside neighboring non-transfected cells, where they often localize in the perinuclear areas ([Figure 7](#fig7){ref-type="fig"}H), reminiscent of the p62 rich aggresome-like structures observed in DRPLA mice ([Figure 6](#fig6){ref-type="fig"}A). Thus, adjacent cells might mask the shedding in the complexity of an *in vivo* model.

In conclusion, our data indicate that LaminB1 and associated proteins are exported from the nucleus and then excreted through a mechanism likely to underlie nuclear and cellular atrophy and death upon chronic autophagy inhibition.

Discussion {#sec3}
==========

The final stages of cell dysfunction and death in neurodegenerative diseases and the atrophy of brain tissue remain elusive in most cases. Recently, the nucleus has received much attention as the organelle whose functionality is severely compromised in aggregation-prone neurodegenerative diseases \[[@bib1], [@bib2]\]. Mutation in genes encoding nuclear lamina constituents cause Hutchinson-Gilford progeria \[[@bib32], [@bib33]\], an accelerated aging syndrome and have been associated with autophagic degradation of nuclear components \[[@bib5]\].

The failure of autophagy in neurodegenerative diseases has been extensively studied and proved to be of paramount importance in most cases \[[@bib6]\]. Our laboratory has previously developed DRPLA *Drosophila* models, in which we have reported defects in autophagic clearance \[[@bib14]\] and transcription of the *fat* cadherin \[[@bib15]\]. We have confirmed these defects in DRPLA mice, including transcription of all mouse Fat genes (data not shown). Here, we show accumulation of undigested autophagosomes and autolysosomes (visualized by TEM), as well as lipofuscin, p62, and GFP cleavage product in the ATN1-FL-65Q mice, indicating insufficient autophagic clearance. Progressive accumulation of p62 in the nucleus acted as a faithful biomarker of cell pathology in the different brain areas (data not shown). However, differently than in *Drosophila*, at the behavioral level we observed gender dimorphism in DRPLA mice, with males being affected more strongly. Furthermore, we provide evidence of a significant effect in terms of activity and exploration due to overexpression of a WT form of human ATN1, a possible gain of function effect, which is absent in the 65Q version and in *Drosophila* models. This highlights the importance of the ATN1-FL-26Q line as an additional control in our analysis, which is in accordance with previous transcriptional analysis reporting 19% of gene expression changes in the ATN1-FL-26Q to be in common with the ATN1-FL-65Q mice but not with a mouse models for Huntington's disease \[[@bib34]\]. Unsurprisingly, we observe several mild phenotypes in ATN1-FL-26Q mice, reflected in increased GFP-LC3 turnover in absence of p62 accumulation and in the reorganization of LaminB1 in the cerebellar cortex. Significant differences between the two ATN1 lines, such as increased accumulation of lipofuscin, of LC3 puncta at end-stage and cleaved GFP in combination with decreased Tfeb expression and that of two of its targets, however, demonstrate that the stall in canonical autophagy flux are solely attributed to the polyQ expansion in the ATN1. Golgi enlargement at end-stage, increase in the senescence marker γH2AX, nuclear shape alterations, and cytoplasmic LC3-associated accumulation of LaminB1 are all specific signs of alternative autophagy induction and subsequent nuclear degeneration in ATN1-FL-65Q animals, absent in ATN1-FL-26Q controls.

The analysis of mouse models and human DRPLA cells has additionally revealed that decreased autophagic degradation is accompanied by alterations in canonical autophagy signaling, which suggests a stall in the formation of new autophagosomes, perhaps resulting from a negative feedback loop. Whereas mTor activity displays a tendency toward inhibition, and thus autophagy induction, the phosphorylation of Atg13 by ULK1, the formation of Atg5-12 conjugates, and the rate of LC3-I/II conversion are all downregulated. This is further compounded by downregulation of Tfeb and at least two of its direct targets. Interestingly, human TFEB has been shown to be involved in auto-regulatory feedback loops in starvation-induced autophagy \[[@bib35]\]. Human DRPLA fibroblasts also failed to induce formation and maturation of autophagosomes following autophagy modulating treatment, consistently with the recently reported defects in Beclin-1-dependent autophagy induction \[[@bib36]\].

In mice, however, the autophagy stall takes place after an initial mild increase in autophagosomes and autolysosomes, possibly driven also by the early moderate ER-stress and Golgi fragmentation. Altogether, our current findings in mice support a model in which neuronal cells challenged by polyQ ATN1 show an overall attempt to induce autophagy but, later on, shut down canonical autophagy signaling, possibly as a result of the inability to progress toward clearance. This suggests that new autophagosomes are not formed through canonical signaling at end-stage, and that the significant accumulation of GFP-LC3 puncta in post-mitotic neurons *in vivo* rather results from lack of digestion and/or alternative routes, including nucleophagy. Human DRPLA fibroblasts *in vitro* do not display the same accumulation of LC3 puncta, presumably because of cell division and of the reduced time window for cell-culture observations.

Recently, alternative autophagy routes, involving some variation of the canonical autophagy steps and signaling, have been discovered, but their role in neurodegenerative diseases has not been described yet.

Here, we detected alternative clearance pathways in DRPLA mice. At end-stage, we observed formation of aggresome-like structures and Golgi enlargement, both cellular correlates for pathological induction of alternative autophagy routes. The aggresomes have been proposed as a cellular pathway for degradation of polyQ \[[@bib37]\] and other aggregation-prone proteins that escape canonical autophagy \[[@bib38]\]. However, since DN neurons lack a proper microtubule organizing center (data not shown), it is unclear whether these structures also meet the functional definition of aggresomes. The Golgi apparatus, and its trafficking with the ER, is disrupted in several examples of neurodegeneration. However, ER-stress markers, in particular, Chop, are downregulated at later stages in DRPLA, perhaps in an attempt to protect cells from apoptotic responses \[[@bib39]\] or as a consequence of lost membrane integrity, incompatible with any further ER-stress induction. Conversely, we provide here the first *in vivo* evidence for GOMED in an autophagy-challenged neuropathology. The Golgi has been reported *in vitro* to engage specifically with autophagy in certain contexts \[[@bib27], [@bib40]\], to be a possible source for autophagic membranes in yeast \[[@bib26]\] and mammals \[[@bib41]\], and to localize in close proximity to phagophores \[[@bib42]\]. The involvement of the Golgi in autophagy is, thus, another indication for extreme autophagy stress in the cerebellar nuclei of DRPLA mice. The downregulation of GFP-LC3II conversion and formation of Golgi-associated autophagic structures in DRPLA mice strikingly resemble the alternative autophagy routes described in *Atg5-* and *Atg7*-defective cells and mice \[[@bib28], [@bib29]\], consistent with a block in canonical autophagy also in DRPLA models.

We thus propose that, upon stalling of the canonical autophagy machinery, cells attempt to maintain homeostasis via alternative routes like GOMED-like degradation and excretion. This, however, leads to irreversible damage, nuclear breakdown, and to terminal cell atrophy and degeneration.

Here, we report the first *in vivo* evidence of a nucleophagy-based mechanism in neurodegeneration, reflected in the association of nuclear LaminB1 with GFP-LC3 in the nucleus and in the cytoplasm, the cytoplasmic accumulation of LaminB1, its degradation and excretion. This process may be responsible for the collapse of normal nuclear structure, which correlates with the progressive accumulation of p62 in the nucleus and the increase in DNA damage and senescence. Because of the lack of substantial co-localization of the LaminB1 puncta with p62, we interpret the p62 accumulation in the nucleus, as a separate event, which occurs either in parallel or as a consequence of the loss of nuclear integrity, and constitutes a reliable biomarker for cellular pathology (unpublished data). TEM pictures revealed irregular nuclear shapes and morphological changes of nuclear membrane, which may be indications for instability of, and leakage from, the nuclear envelope. This was further backed by the alteration of LaminB structure in both fly and mouse models for DRPLA and in human fibroblasts from DRPLA and VS patients, as well as in human neuroblastoma cells with inhibited autophagy. The export to the cytoplasm of nuclear LaminB1 is likely to underlie the severe defects in nuclear shape, causing disruption of nuclear integrity, which can be sensibly connected to large-scale transcriptional aberrations, nucleo-cytoplasmic transport, and terminal cell degeneration, all key features of human neurodegeneration.

We speculate that in normal cells a low degree of nucleophagy and of LaminB1 excretion might be an attempt at maintaining nuclear health by rejuvenating nuclear lamina and perhaps disposing of other nuclear proteins through autophagy and excretion. In DRPLA, this may be an attempt to counteract the effect of polyQ ATN1. This protein has been reported to interact with nuclear matrix components at discrete locations \[[@bib43]\], and we observe a striking co-localization between LaminB1 and polyQ aggregates both in the nucleus and in the cytoplasm.

Once LaminB1 is exported into the cytoplasm, it is cleaved and degraded through two independent pathways, the autophagy-lysosome and GOMED-like systems. A small portion is excreted also in healthy cells. However, when the canonical autophagy-lysosome pathway is impaired, the cytoplasmic LaminB1 is increasingly channeled for excretion, together with p62 in large microvesicles or exophers \[[@bib44]\].

We hypothesize that this excretion process is a clearance mechanism for the cell, alternative to lysosomal and Golgi-mediated degradation; however, with the potential consequence of causing cell and tissue atrophy. While the function of the basal excretion of LaminB1-rich buds remains to be understood, the exacerbated excretion under autophagy and Golgi impairment represents a novel mechanism for cell atrophy and death. In absence of effective degradation and recycling of the basic components, this process depletes the cell of material, damaging its nucleus and cytoplasm and leaving behind cell corpses with a fragile nucleus and thin cytoplasmic layer. In our experiments, *in vivo* and *in vitro*, cytoplasmic accumulation and excretion of LaminB1 correlated with an increase in cell death, misshapen nuclei, and cell atrophy.

The common factor underling this mechanism of cell atrophy and death is a persistent block in autophagy. Since chronic autophagy inhibition has been reported in an increasing number of rare and common human neurodegenerative pathologies, the mechanism here reported may therefore be of great relevance in human disease.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**rabbit α-Lamp2aAbcamCat\#ab18528; RRID: [AB_775981](nif-antibody:AB_775981){#interref0010}mouse α-p62AbnovaCat\#H00008878-M01; RRID: [AB_548364](nif-antibody:AB_548364){#interref0015}rabbit α-LaminB1AbcamCat\#ab16048; RRID: [AB_10107828](nif-antibody:AB_10107828){#interref0020}mouse α-GM130BD Transduction Lab,Cat\#010823; RRID: [AB_398142](nif-antibody:AB_398142){#interref0025}mouse α-PolyQChemiconCat\#MAB1574; RRID: [AB_94263](nif-antibody:AB_94263){#interref0030}mouse α-dmLaminBDSHBCat\#ADL67.10; RRID: [AB_528336](nif-antibody:AB_528336){#interref0035}mouse α-γ-H2AXMilliporeCat\#05-636; RRID: [AB_309864](nif-antibody:AB_309864){#interref0040}rabbit α-TFEBBethyl LabsCat\#A303-673A; RRID: [AB_11204751](nif-antibody:AB_11204751){#interref0045}rabbit α-Atg5Novus BiologicalCat\#NB110-53818; RRID: [AB_828587](nif-antibody:AB_828587){#interref0050}rabbit α-Atg13-P-S318RocklandCat\#600-401-C49S (Lot 27919); RRID: [AB_11181153](nif-antibody:AB_11181153){#interref0055}rabbit α-phospho-p70S6KCell SignalingCat\#9205S; RRID: [AB_330944](nif-antibody:AB_330944){#interref0060}mouse α--α-tubulinSIGMACat\#T9026; RRID: [AB_477593](nif-antibody:AB_477593){#interref0065}chicken α-MAP2AbcamCat\#ab5392; RRID: [AB_2138153](nif-antibody:AB_2138153){#interref0070}**Chemicals, Peptides, and Recombinant Proteins**Bafilomycin A1SIGMACat\#B1793RapamycinCalbiochemCat\#553210Brefeldin ASIGMACat\#B7651Lipofectamine3000 reagentInvitrogenCat\#L3000-008TRI ReagentInvitrogenCat\#T9424SuperScript III Reverse TranscriptaseInvitrogenCat\#18080-051**Critical Commercial Assays**UPL libraryRocheN/ATaqMan Universal PCR Master mixThermoFisher ScientificCat\#4304437SuperSignal West Pico Chemiluminescent SubstrateThermoFisher ScientificCat\#34080**Experimental Models: Cell Lines**SK-N-BE(2)ATCCATTC: CRL-2271**Experimental Models: Organisms/Strains**Mouse: C3;B6-Tg(Prnp-ATN1)84Dbo/MmmhMMRRC repositoryRRID: MMRRC_000396-MUMouse: C3;B6-Tg(Prnp-ATN1)150Dbo/MmmhMMRRC repositoryRRID: MMRRC_000398-MUMouse: B6CBAF1/OlaHsdHarlan Olac, Bicester, UKN/AMouse: B6.Tg(CAG-GFP-LC3)\[[@bib18]\]MTA G. Bates*D. melanogaster: Elav-Gal4;Repo-Gal4,ubi-Gal80*^*ts*^This paperN/A*D. melanogaster: UAS-LacZ*BDSC\#8529*D. melanogaster: UAS-sAtro*^*75QN*^.\[[@bib14]\]N/AEpg5 p.Phe1604Glyfs^∗^20 fibroblasts\[[@bib21]\]N/AHuman fibroblasts DRPLA17CorriellCoriell: GM13717Human fibroblasts DRPLA16CorriellCoriell: GM13716Human fibroblasts control, m, 51MRC CNMD Biobank LondonUN3373Human fibroblasts control, m, 3\[[@bib21]\]N/A**Oligonucleotides**Atg5 siRNA (5′-GGU UUG GAC GAA UUC CAA CUU GUU U-3′)Eurofins Genomix; \[[@bib45]\]N/AAtg6 siRNA (5′-ACA GUG AAU UUA AAC GAC AGC AGC U-3′)Eurofins Genomix; \[[@bib45]\]N/Anon-specific control siRNA (5′-AGG UAG UGU AAU CGC CUU G-3′, 47%CG)Eurofins GenomixN/APrimer: *Hprt1* Forward: cctcctcagaccgcttttt Reverse: aacctggttcatcat\
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Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Manolis Fanto (<manolis.fanto@kcl.ac.uk>).

Experimental Models and Subject Details {#sec4.3}
---------------------------------------

### Drosophila {#sec4.3.1}

The following mutant fly stocks were used: *Elav-Gal4, Repo-Gal4, ubi-Gal80*^*ts*^*, UAS-LacZ, UAS-sAtro*^*75QN*^. *Elav-Gal4;Repo-Gal4,ubi-Gal80*^*ts*^ virgin females were crossed to males from the *UAS-LacZ* and *UAS-sAtro*^*75QN*^ stocks. After development at 18°C the F1 progeny was transferred to 29°C. 14 days old females were used for immunofluorescence.

### Animals {#sec4.3.2}

All experimental procedures involving mice were carried out under a license from the Home Office according to regulations set by the Animals (Scientific Procedures) Act 1986 (ASPA). Reporting of animal experiments is in accordance to the ARRIVE guidelines \[[@bib48]\]. The two DRPLA mouse strains C3;B6-Tg(Prnp-ATN1)84Dbo/Mmmh (26Q) and C3;B6-Tg(Prnp-ATN1)150Dbo/Mmmh (65Q) \[[@bib12]\] were recovered from the MMRRC repository and maintained by backcrossing to (CBA/Ca x C57BL/6J)F1 animals, B6CBAF1/OlaHsd (Harlan Olac, Bicester, UK), often used to analyze behavior in the R6/2 HD mouse models \[[@bib49]\]. The double mutants heterozygous for GFP-LC3 and DRPLA were achieved by crossing ATN1-FL-26Q-84 and ATN1-FL-65Q-150 lines to the B6.Tg(CAG-GFP-LC3) \[[@bib18]\] autophagy reporter line. Genotyping was performed by PCR using ear biopsies. Primers: PrP- FW: 5′-CTCTTTGTGACTATGTGGACTGATGTCGG-3′, PrP-RV: 5′-GTGGATACCCCCTCCCCCAGCCTAGACC-3′, At-3818: 5′-GGTGGGGAGGTGGCGAGGAT-3′, GFP(LC3): 5′-TCCTGCTGGAGTTCGTGACCG-3′, and LC3^∗^rc3: 5′-TTGCGAATTCTCAGCCGTCTTCATCTCTCTCTCGC-3′. PCR conditions were 95°C for 30 s, 58°C for 30 s, and 72°C for 60 s for a total of 34 cycles. Animals were housed under 12 h light/12 h dark cycle (7am to 7pm light), with unlimited access to water and food (Special Diet Service, Witham, UK) in a conventional unit. All animals were immunocompetent and drug naive. Cages were environmentally enriched with a cardboard hut, tube, and bale of shredded paper. The wild-type, ATN1-FL-26Q, and ATN1-FL-65Q were kept in separate cages with 4-6 animals per cage. 6 groups of mice with 8-10 animals per genotype and gender were exposed to repetitive behavioral testing from four weeks of age in the hours 13:00--17:00 on same days of the week. The double-, single- and non-transgenic animals were selected from the same litters, hereby preferably selecting the wild-type control littermates from the heterozygous ATN1-FL-65Q to GFP-LC3 crosses. Grip strength and rotarod performance were tested every four weeks. Open-field experiments were performed at 10 weeks for both sexes as well as at 14 weeks for females only. The mice were separated in two rounds consisting of 13 experimental units for rotarod performance. Females were tested prior to males. For open field the mice were randomly distributed into the four experimental arenas with all three genotypes represented at a time. The behaviorally assessed animals were repurposed for further phenotyping procedures, such as morphological and biochemical analysis after reaching the end-stage (Supplemental table S1). The end-stage was defined as 20 weeks for males and 24 weeks for females using the distress scale.

### Cell culture {#sec4.3.3}

Human fibroblasts DRPLA17 (Corriell GM13717, male, age 47, 65Q), DRPLA16 (Corriell GM13716, male, age 15, 68Q), age matched control to DRPLA17 (male, age 51), Vici syndrome fibroblasts (Epg5 p.Phe1604Glyfs^∗^20, male, age 3), age matched controls to Vici syndrome (male, age 3) \[[@bib21]\] are derived from skin biopsies. Human neuroblastoma cell line SK-N-BE(2) was purchased from ATTC (CRL-2271). This brain neuroblasts are derived originally from a bone marrow metastasis of 2 year old male individual. All cells were cultured in DMEM high glucose with 10% (v/v) FCS, 1 mM sodium-pyruvate, penicillin/ streptomycin and L-Glutamine.

Method Details {#sec4.4}
--------------

### Behavioral analysis {#sec4.4.1}

#### Rotarod performance {#sec4.4.1.1}

Motor coordination was tested on an accelerating rotarod, by placing mice individually on an accelerating, rotating beam (4-40 rpm) for a maximum of five min as previously described \[[@bib50]\]. Latency to fall was recorded as time (sec) the mouse was able to remain on the beam. Mice were exposed consecutively to three trials per day with two habituation and two experimental days at four weeks age and one habituation and two experimental days for following stages. The mice were separated in two rounds consisting of 13 experimental units. Animals of each unit were of the same genotype and age housed in one numbered cage. The experimenter was blind to the genotype of the experimental animals and units coded by numbers. Females were tested prior to males. The apparatus was thoroughly cleaned using 70% ethanol after each trial. The averages from replicates from three experimental trials and two experimental days were calculated for each animal and subjected to statistical analysis (n = 8-10).

#### Grip strength {#sec4.4.1.2}

Grip strength capacity was assessed as previously described on the habituation day prior to the rotarod performance analysis \[[@bib51]\]. Three independent measurements of the strength of the forelimbs only, as well as fore- and hind limbs taken together were averaged as technical replicates. Mice were guided along wire-mesh grid attached to a grip strength monitor (Bioseb *In Vivo* Research Instruments) by holding them at the base of the tail. Mice were either allowed to grip with forelimbs only, or fore- and hind limbs together. The maximum tension was recorded (g) by gently pulling the mouse away from the apparatus. Females were tested prior to males. The experimenter was blind to the genotype of the experimental animals coded by numbers. The averages from replicates of the three experimental trials were calculated for each animal and subjected to statistical analysis (n = 8-10).

#### Open field {#sec4.4.1.3}

The locomotive behavior was analyzed by placing mice individually into square, plain white open field arenas (50 × 50 × 50 cm, Engineering & Design Plastics, Cambridge, UK) for 30 min. The spatiotemporal position of the individual animal was recorded through a video camera positioned above the apparatus and respective individual trails were tracked and later analyzed using EthoVision 7XT software (Noldus, Netherlands) as previously described \[[@bib51]\]. Exploratory activity in a novel, unfamiliar environment was assessed as the distance traveled (cm) over the total area in the first five min after introduction to the open field. Thigmotaxis, the time (s) spent in the peripheral, outer-zone of an open field is indicative of an anxiety-like behavior \[[@bib16]\], and was analyzed likewise during the first five min after introduction to the novel environment. The open field arena was divided into two square zones, with outer zone 50 × 50 cm and inner zone with 40 × 40 cm. The general activity was analyzed between five and 25 min after the introduction to the open field as a distance traveled (cm) during the given 20 min interval. The mice were randomly distributed into the four experimental arenas with all three genotypes represented at a time. The open field arena was thoroughly cleaned using 70% ethanol after each trial.

#### Gait analysis {#sec4.4.1.4}

For the gait analysis non-toxic finger paint was applied on the front (blue) and back (red) paws of the mice and the mice were allowed to walk through a transparent corridor (5 cm x 1 m) toward a dark chamber.

### Transmission electron microscopy {#sec4.4.2}

The single transgenic DRPLA mice were transcardially perfused with physiological saline solution followed by filtered 2.5% (v/v) EM grade glutaraldehyde and 2% (v/v) EM grade paraformaldehyde in 0.1cM sodium cacodylate buffer. The dissected brains were post-fixed for 24 h and kept at 4°C in 0.1cM sodium cacodylate buffer until further processing. 120 μm thick vibratome slices were postfixed in 1% (v/v) osmium tetroxide in 0.1cM sodium cacodylate buffer, followed by en bloc contrasting in 1% (w/v) uranyl acetate for 45 min. The coronal brain slices were gradually dehydrated in ethanol and propylene oxide and finally infiltrated and embedded in TAAB embedding resin premix (T028H). The resin embedded slices were trimmed to expose the anatomic region corresponding to the dentate nucleus and processed at the microtome to retrieve gold sections (∼90 nm). The ultrathin sections were additionally contrasted with uranyl acetate and lead citrate and viewed on a FEI Tecnai T12 electron microscope operated at 120kV. Images were acquired with an AMT 16000M camera.

### Plasmids and siRNAs {#sec4.4.3}

*p(RFP)-EGFP-LC3B* (gift from P. Codogno), *pEGFP-N1*, *mCherry-LaminB1-10 (Addgene, \#55069)*. The previously published \[[@bib45]\] Atg5 siRNA (5′-GGU UUG GAC GAA UUC CAA CUU GUU U-3), Atg6 siRNA (5′-ACA GUG AAU UUA AAC GAC AGC AGC U-3′) and non-specific control siRNA (5′-AGG UAG UGU AAU CGC CUU G-3′, 47%CG) were obtained from Eurofins Genomix and lyophilized in supplied RNAmax buffer.

### Cell culture treatments and autophagy flux analysis {#sec4.4.4}

Treatment with 1μM Rap, 10 nM BafA1 and 0.1% of solvent DMSO, respectively, were performed for 6, 24, 48 or72 hr for assessment of autophagy flux. For analysis of LaminB1 accumulation and end excretion cells were treated for 24 hr with DMSO or BafA1, followed by replacement of the medium with DMSO, BafA1, 1 μM BrefA or BafA1/BrefA combination after rinsing with PBS. Cells were fixed in 4% paraformaldehyde for 15 min and washed in PBS. The immunocytochemical evaluation was performed in 96-well plate format using Opera Phenix system and Columbus software. Cells were transiently transfected using Lipofectamine3000 reagent (Invitrogen) according to the manufactures protocol. For assessment of autophagy flux fibroblasts were starved in HBSS or treated with 10 nM BafA1 for 3 hr and analyzed with life imaging using Nikon Spining disc confocal microscope.

### Perfusion and tissue processing {#sec4.4.5}

The wild-type, single transgenic or double transgenic mice (n = 6 per group) were transcardially perfused with ice cold physiological saline solution followed by filtered 4% (w/v) paraformaldehyde in phosphate buffered saline (PBS). The dissected brains were postfixed overnight, cryopreserved in 30% (w/v) sucrose in PBS, and embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek). Serial coronal free floating cryosections were collected at 30 μm thickness using Microm cryostat (Thermo Scientific), and stored in antifreeze solution (40% (v/v) PBS, 30% (v/v) Glycerol and 30% (v/v) Ethylenglycol) at −20°C until further processing.

### Immunohistochemistry and cytochemistry {#sec4.4.6}

To avoid nonspecific binding and for permeabilization the sections or fixed cells were incubated in blocking solution (5% (v/v) normal goat serum, 1% (w/v) bovine serum albumin (BSA), 0.5% (v/v) Triton X-100 in PBS). For some mouse antibodies additional blocking of endogenous mouse IgGs with 0.1 mg/ml of α-mouse IgG Fab fragments (Zenon Kit, Invitrogen) was necessary. The antibodies were incubated in carrier solution (1% (v/v) normal goat serum, 1% (w/v) bovine serum albumin (BSA), 0.5% (v/v) Triton X-100 in PBS). Incubation of primary antibodies was performed for 48 hr at 4°C on an orbital shaker. Secondary antibodies were applied for 4 hr at room temperature. Primary antibodies: mouse α-GFP (1:500, Roche), rabbit α-GFP (1:5000, Life technologies, A11122), rabbit α-Lamp2a (1:2000, Abcam, ab18528), mouse α-p62 (1:2000, Abnova, H00008878-M01), rabbit α-LaminB1 (1:1000, Abcam, ab16048), mouse α-GM130 (BD Transduction Lab, 010823), mouse α-PolyQ (1:1000, Chemicon, IC2), mouse α-dmLaminB (1:500, DSHB), chicken α-MAP2 (1:1000, Abcam, ab5392), mouse α-γH2AX (1:1000, Millipore), rabbit α-TFEB (1:200, Bethyl Labs). A555,A488 or A633 conjugated goat α-mouse, α-rabbit or α-chicken secondary antibodies (1:500, Invitrogen) were used. To remove lipofuscin-like autofluorescence the stained sections were bleached with 10 nm CuSO~4~ in ammonium acetate buffer (pH = 4.8) for 20 min \[[@bib52]\] without affecting the specific antibody staining ([Figure S2](#mmc1){ref-type="supplementary-material"}). To reveal the cell nuclei fluorescent dye Hoechst 33342 was applied in a concentration of 0.1 mg/ml in PBS for five min. Slices were mounted on microscopic slides in fluorescent mounting medium (DAKO). Confocal images of 40 to 90 cells were taken from 3 to 6 animals and analyzed morphometrically with experimenter being blinded to the genotype. Cells were imaged directly in multiwell plates in PBS and subjected to automated morphometric analysis.

### Western blot analysis {#sec4.4.7}

#### In vivo brain lysates {#sec4.4.7.1}

Double transgenic mice (three per genotype and stage) were sacrificed by cervical dislocation followed by decapitation. The brains were dissected in ice cold PBS under a stereomicroscope. The two forebrain hemispheres were separated by medio-sagittal incision and detached form the diencephalon by an inclined cut to separate connecting fibers. The cerebellum was separated by disruption of cerebellar peduncles. The remaining parts comprising diencephalon, midbrain, pons, and formatio reticularis are referred to as the brainstem. The tissue was deep frozen in liquid nitrogen and stored at −80°C. The tissue was homogenized in modified RIPA buffer (137 mM NaCl, 20 mM Tris-HCl pH 7.5, 25 mM sodium glycerophosphate, 2 mM EDTA, 1 mM sodium-orthovanadate, 1% (v/v) IGEPAL CA-630, 1% (w/v) deoxycholate, supplemented with Complete protease inhibitor cocktail (Roche)) using plastic pestles followed by three times repeated freezing in liquid nitrogen and thawing on ice. The supernatant was retrieved by 15 min centrifugation at full speed in Haereus Biofuge fresco (40474211, Kendro, rotor \# 3328) cooled to 4°C. The pellet consisting of white top unconstrained fraction and transparent agglutinated bottom fraction was resuspended in homogenization buffer and homogenized by sonication (Brandelin Sonoplus UW2070).

#### Whole-cell lysates {#sec4.4.7.2}

Human fibroblast cultures were rinsed with PBS, lysed in modified RIPA buffer, scraped from the Petri dish incubated for 15 min on ice and centrifuged for 15 min at 4°C. Supernatants were subjected to analysis. The experiment was repeated three times on three independent days (n = 3). The lysates from the three independent experiments were loaded on one SDS-PAGE gel and densitometric evaluation of the western blot analysis was performed on the resulting triplicates.

#### Excretion analysis {#sec4.4.7.3}

Extracellular vesicle isolation via gradual ultracentrifugation and cytoplasmic and nuclear preparation were performed as described in \[[@bib53]\]. Medium was removed from the cells and subjected to three centrifugation steps at 300 g, 10,000 g and 100,000 g at 4°C. The final pellet was washed in PBS and lysed in 1x Laemmli buffer. The results of from five independent experiments were subjected to statistical analysis.

#### Nuclear and cytoplasmic preparations {#sec4.4.7.4}

after aspiration of the medium the cells were washed in ice-cold PBS, detached with Trypsin-EDTA, washed in PBS and harvested in hypoosmotic homogenization buffer (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT, 25 mM NaF, 1 mMNaVO~3~, PhosStop (Roche Applied Science), Complete protease inhibitor mixture (Roche Applied Science)). After incubation on ice for 15 min, the cells were lysed by the addition of 0.6% (v/v) Igepal CA-630 and vigorous vortexing. After centrifugation, the supernatant representing the cytoplasmic fraction was saved. The nuclear pellet was washed twice in homogenization buffer containing 0.6% (v/v) Igepal. The supernatant of the two washes was added to the cytoplasmic fraction. The nuclear pellet was dissolved by sonication in modified RIPA buffer. The results from five independent experiments subjected to western blot analysis were evaluated statistically.

#### SDS-PAGE and western blot assay {#sec4.4.7.5}

Protein concentration was determined using BCA assay kit (ThermoFischer Scientific) according to the manufacturer's protocol using a microplate reader at 495 nm. The protein lysates were denaturated in Laemmli buffer for 5 min at 95°C, followed by separation using SDS-PAGE by loading 100 μg of supernatant protein and 50 μg of pellet protein, respectively, and transferred onto nitrocellulose membrane (ECL, 0.2 μm pore size, Amersham) using BioRad Mini-Protean and Mini-Trans-Cell systems. Unspecific binding was blocked with 5% (w/v) low-fat milk powder or 5% (w/v) BSA in Tris-buffered saline supplemented with 0.1% (v/v) tween (TBST). The primary antibodies were incubated in blocking solution overnight at 4°C. Primary antibodies: mouse α-GFP (1:1000, Roche), rabbit α-LC3 (1:5000, MBL, PD014), mouse α-p62 (1:5000, Abnova, H00008878-M01), rabbit α-phospho-p70S6K (1:1000, Cell Signaling, 9205S), rabbit α-Atg5 (1:500, Novus Biological), rabbit α-Atg13-P-S318 (1:2000, Rockland) and mouse α--α-tubulin (1:20000, SIGMA, T9026). The HRP conjugated secondary α-mouse and α-rabbit antibodies (1:2500, Calbiochem). The α-LC3 antibody recognized the classic doublet for GFP-LC3 in the supernatant, but only the lower band, corresponding to LC3-II, was detected in the pellet of in-vivo tissue lysates ([Figure S4](#mmc1){ref-type="supplementary-material"}B). The mouse α-GFP antibody only recognized this lower band in both supernatant and pellet of *in vivo* tissue lysates ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Secondary antibodies were incubated in 5% (w/v) low-fat milk powder in TBST for 1 h at room temperature. All specific signals were detected at the predicted molecular weight according to the molecular weight marker using SuperSignal West Pico Chemiluminescent Substrate (ThermoFisher Scientific). The densitometric analysis was performed using Image Studio Lite software (Li-Cor).

### RNA extraction and quantitative RT-PCR {#sec4.4.8}

The cerebellum was dissected from wild-type, 26Q and 65Q mice (n = 6). The tissue was snap frozen in liquid nitrogen and stored at −80°C. The phenol/chlorophorm RNA extraction was performed using TRI Reagent (Invitrogen) according to the manufacturer's protocol. cDNA was generated using SuperScript III Reverse Transcriptase (Invitrogen). To quantify expression levels of *Tfeb*, cDNA template was amplified using UPL-based (UPL library, Roche) qPCR in combination with TaqMan Universal PCR Master mix on ABI 7900HT real-time PCR system (Applied Biosystems). For quantification (averages from triplicates) of expression levels of ER stress response and Tfeb target genes real-time qPCR was performed using the Light Cycler 480 system (Roche Applied Science, Indianapolis, IN, USA) as previously described \[[@bib54]\]. All sequences used for the quantification are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Morphometric analysis {#sec4.5.1}

For Golgi size, H2AX, LaminB1, GFP-LC3, Lamp2a and GFP-RFP-LC3 puncta quantification was performed using ImageJ software. Confocal images of 40 to 90 cells from 3 to 6 animals were subjected to background subtraction, automatic thresholding (default and rely entropy, respectively) and particle analysis. For particle area, size, and number, 'analyze particles' command on binary images was applied. For intensity values gray level images were assessed after background subtraction. Colocalization analysis performed using images from the 'Green and Red Puncta Colocalization' macro \[[@bib47]\]. Lipofuscin quantification was performed manually using the cell counter tool in ImageJ. The automated quantification of LaminB1 inclusions in the cytoplasm was performed using Columbus software. The cellular regions were defined using functions such as find nuclei (Hoechst), find cytoplasm (LaminB1 background or EGFP) and find surrounding region for extracellular LaminB1 spots. Select population was applied to analyze whole cells only or to separate EGFP-positive from untransfected non-EGFP positive cells. The nuclear shape was analyzed using STAR shape analysis (area, roundness). Find spots function was employed for detection of LaminB1 or p62 specifically in the cytoplasm region as puncta per cell or, in cases of varied puncta size, area occupied by puncta per cell. The analysis was performed in at least 3 or 5 replicates including random selection of 20-40 imaging fields with multiple cells.

### Statistical analysis {#sec4.5.2}

All quantifications were done manually in blind, unless otherwise stated. Statistical analysis was performed using Microsoft Excel and GraphPad Prism software. The data were tested for normality and equal variances using two-sided Z-test and F-test function in Excel as well as column statistics and Kolmogorov-Smirnov test in GraphPad prism. Subsequent comparison of differences between groups (genotypes, treatments) was assessed with adequate parametric and non-parametric tests for two group (Student's t test, Mann-Whittney) or multiple group comparisons (one-way ANOVA, Kruskal-Wallis). For comparison of two variables, e.g., genotype and treatment, at a time (variable1 = v1, variable2 = v2) two-way ANOVA was employed.

For animal experiments power calculations were not performed due to the exploratory nature of this study. Behavioral data were tested for significant differences using repeated-measures two-way ANOVA, thereby separating males (n ≥ 8) and females (n ≥ 8), since the values of control animals varied significantly between sexes. No significant differences were detected between the animals from the two rounds behavioral analysis, nor animals expressing GFP-LC3 in addition to ATN1 transgene. In the histological and qPCR analysis no differences between males (n = 3) and females (n = 3) were evident. Therefore statistical significances were analyzed between mixed gender groups using one-way ANOVA, unless otherwise stated. For western blot assays the densitometric data (males, n = 3) was analyzed using unpaired Student's t test, unless otherwise stated.
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Document S1. Figures S1--S7Table S1. Experimental Timeline and List of Animals Used for Specified Experimental Procedures, Related to STAR MethodsMovie S1. End-Stage Behavior of ATN1-FL-65Q, Related to Figure 1End-stage ATN1-FL-65Q male imminent to terminal point showing hunched posture, piloerection, and generalised tremors, as well as occasional jerk movements and freezing behavior.Movie S2. Rotarod Activity, Related to Figure 1Representative examples of the performance on the rotarod for wild type (left), ATN1-FL-26Q (middle) and ATN1-FL-65Q (right) females at 12 weeks. The testing was performed at 4-5 hr before the switch to the dark period. The wild type mice showed a rather laborious and ponderous impression from the start, while able to retain on the rod. The ATN1-FL-26Q showed a rather versatile and skilful performance, showing excellent balance on the rod including initial body turns, curiosity, and explorative behavior. The ATN1-FL-65Q mice show a tendency to reduced balance, using rather mincing steps on the very top surface of the rod and increasingly supporting the balance with the tail to remain on the rod.Movie S3. Excretion of LaminB1 from Human Neuroblastoma Cells, Related to Figure 7Live imaging of the cell shown in Figure 7B showing the detachment of an mCherry-LaminB1 punctum from the nucleus until its excretion from the EGFP marked cytoplasm. Note that after excretion the particle still appear attached to the cell.Document S2. Article plus Supplemental Information
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